Pleiotrophin increases neurite length and number of spiral ganglion neurons in vitro

• Published in: Experimental brain research 2019-11, Vol.237 (11), p.2983-2993
• Main Authors: Bertram, Sebastian, Roll, Lars, Reinhard, Jacqueline, Groß, Katharina, Dazert, Stefan, Faissner, Andreas, Volkenstein, Stefan
• Format: Article
• Language: English
• Subjects: Aging; Animals; Auditory discrimination; Biomedical and Life Sciences; Biomedicine; Brain stem; Carrier Proteins - physiology; Cell death; Cochlea; Cytokines - deficiency; Cytokines - physiology; Degeneration; Evoked Potentials, Auditory, Brain Stem - physiology; Explants; Female; Hearing loss; Hearing Loss, Sensorineural - pathology; Hearing Loss, Sensorineural - physiopathology; Hearing protection; HEK293 Cells; Humans; Inner ear; Lymphoma; Male; Mice; Mice, Knockout; mRNA; Neurites - physiology; Neurology; Neurons; Neurons - physiology; Neurosciences; Neurotrophic factors; Ototoxicity; Pleiotrophin; Protein-tyrosine kinase; Protein-tyrosine-phosphatase; Receptor density; Research Article; Spiral ganglion; Spiral Ganglion - physiology; Syndecan; Trauma
• ISSN: 0014-4819; 1432-1106
• DOI: 10.1007/s00221-019-05644-6

Acoustic trauma, aging, genetic defects or ototoxic drugs are causes for sensorineural hearing loss involving sensory hair cell death and secondary degeneration of spiral ganglion neurons. Auditory implants are the only available therapy for severe to profound sensorineural hearing loss when hearing aids do not provide a sufficient speech discrimination anymore. Neurotrophic factors represent potential therapeutic candidates to improve the performance of cochlear implants (CIs) by the support of spiral ganglion neurons (SGNs). Here, we investigated the effect of pleiotrophin (PTN), a well-described neurotrophic factor for different types of neurons that is expressed in the postnatal mouse cochlea. PTN knockout mice exhibit severe deficits in auditory brainstem responses, which indicates the importance of PTN in inner ear development and function and makes it a promising candidate to support SGNs. Using organotypic explants and dissociated SGN cultures, we investigated the influence of PTN on the number of neurons, neurite number and neurite length. PTN significantly increased the number and neurite length of dissociated SGNs. We further verified the expression of important PTN-associated receptors in the SG. mRNA of anaplastic lymphoma kinase, α v integrin, β 3 integrin, receptor protein tyrosine phosphatase β/ζ, neuroglycan C, low-density lipoprotein receptor-related protein 1 and syndecan 3 was detected in the inner ear. These results suggest that PTN may be a novel candidate to improve sensorineural hearing loss treatment in the future.